BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38698327)

  • 1. Efficacy of sucrose and povidone-iodine mixtures in peritoneal dialysis catheter exit-site care.
    Nakayama T; Morimoto K; Uchiyama K; Washida N; Kusahana E; Hama EY; Mitsuno R; Tonomura S; Yoshimoto N; Hishikawa A; Hagiwara A; Azegami T; Yoshino J; Monkawa T; Yoshida T; Yamaguchi S; Hayashi K
    BMC Nephrol; 2024 May; 25(1):151. PubMed ID: 38698327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
    Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparison of exit-site care with normal saline and povidone-iodine in preventing exit-site infection and peritonitis in children on chronic peritoneal dialysis treatment.
    Yavascan O; Anil M; Kara OD; Bal A; Akcan N; Senturk S; Unturk S; Aksu N
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):931-4. PubMed ID: 21912021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
    Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
    Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Retrospective Sequential Comparison of Topical Application of Medicated Honey and Povidone Iodine for Preventing Peritoneal Dialysis Catheter-Related Infections.
    Wishart TFL; Aw L; Byth K; Rangan G; Sud K
    Perit Dial Int; 2018; 38(4):302-305. PubMed ID: 29987066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Local Polyhexanide Application in Preventing Exit-Site Infection and Peritonitis: A Randomized Controlled Trial.
    Ceri M; Yilmaz SR; Unverdi S; Kurultak I; Duranay M
    Ther Apher Dial; 2020 Feb; 24(1):81-84. PubMed ID: 31066988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fungal peritoneal dialysis catheter-related exit-site infection combined with tunnel infection: A case report].
    Qiao J; Lu LX; He YT; Men CC; Chu XX; Wu B; Zhao HP; Wang M
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):748-754. PubMed ID: 37534662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorhexidine-impregnated sponge dressing for prevention of catheter exit-site infection in peritoneal dialysis patients: a pilot study.
    Htay H; Choo JCJ; Johnson DW; Pascoe EM; Jayaballa M; Oei EL; Ng LC; Wu SY; Foo MWY
    Int Urol Nephrol; 2021 Apr; 53(4):803-812. PubMed ID: 33025409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exit site and tunnel infections in children on chronic peritoneal dialysis: findings from the Standardizing Care to Improve Outcomes in Pediatric End Stage Renal Disease (SCOPE) Collaborative.
    Swartz SJ; Neu A; Skversky Mason A; Richardson T; Rodean J; Lawlor J; Warady B; Somers MJG
    Pediatr Nephrol; 2018 Jun; 33(6):1029-1035. PubMed ID: 29480421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between glycemic control and the incidence of peritoneal and catheter tunnel and exit-site infections in diabetic patients undergoing peritoneal dialysis.
    Rodríguez-Carmona A; Pérez-Fontán M; López-Muñiz A; Ferreiro-Hermida T; García-Falcón T
    Perit Dial Int; 2014; 34(6):618-26. PubMed ID: 23818005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exit-site care in peritoneal dialysis.
    Wadhwa NK; Reddy GH
    Contrib Nephrol; 2007; 154():117-124. PubMed ID: 17099306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exit-site infection of peritoneal catheter is reduced by the use of polyhexanide. results of a prospective randomized trial.
    Núñez-Moral M; Sánchez-Álvarez E; González-Díaz I; Peláez-Requejo B; Fernández-Viña A; Quintana-Fernández A; Rodríguez-Suárez C
    Perit Dial Int; 2014 May; 34(3):271-7. PubMed ID: 24497599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and risk factors of exit-site infection in incident peritoneal dialysis patients.
    Lin J; Ye H; Li J; Qiu Y; Wu H; Yi C; Lu S; Chen J; Mao H; Huang F; Yu X; Yang X
    Perit Dial Int; 2020 Mar; 40(2):164-170. PubMed ID: 32072873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter revision for the treatment of intractable exit site infection/tunnel infection in peritoneal dialysis patients: a single centre experience.
    Cho KH; DO JY; Park JW; Yoon KW
    Nephrology (Carlton); 2012 Nov; 17(8):760-6. PubMed ID: 22804821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
    Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
    Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in catheter-related infections after switching from povidone-iodine to chlorhexidine for the exit-site care of tunneled central venous catheters in children on hemodialysis.
    Paglialonga F; Consolo S; Biasuzzi A; Assomou J; Gattarello E; Patricelli MG; Giannini A; Chidini G; Napolitano L; Edefonti A
    Hemodial Int; 2014 Oct; 18 Suppl 1():S13-8. PubMed ID: 25330826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between exit site infection and subsequent peritonitis among peritoneal dialysis patients.
    van Diepen AT; Tomlinson GA; Jassal SV
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1266-71. PubMed ID: 22745277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Targets for Prevention of Peritoneal Catheter Tunnel and Exit-Site Infections in Low Incidence Settings.
    Santos C; Pérez-Fontán M; Rodríguez-Carmona A; Calvo-Rodríguez M; López-Muñiz A; López-Calviño B; García-Falcón T
    Perit Dial Int; 2016; 36(1):43-51. PubMed ID: 25292406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.